5-amino-1MQ – 50mg x 30 capsules
115,99 €
What is 5-Amino-1MQ?
5-Amino-1MQ is a small research molecule that inhibits the enzyme NNMT – which regulates NAD⁺ levels and affects cellular metabolism. In preclinical tests, it has shown potential in areas such as fat loss, performance enhancement and cellular renewal.
Effects studied
- Support for body fat reduction
- Maintenance or increase in muscle mass
- Support for mitochondrial metabolism
- Increase in NAD⁺ levels
- Potential use in obesity, diabetes and regeneration research

How does 5-Amino-1MQ work?
The mechanism of action is to block the NNMT enzyme, thereby increasing NAD⁺ levels. This has the effect of improving mitochondrial function, metabolism and endurance. In studies on mice, there was an increase in performance and a decrease in body fat without loss of muscle mass.
Dosage in studies
- Form of administration: subcutaneous administration in mice
- Dose: 10 mg/kg/day
- Duration: 8 weeks
- Population: older mice (22 months)
5-Amino-1MQ is a small molecule and inhibitor of the enzyme NNMT (nicotinamide N-methyltransferase) that is being studied in laboratory conditions for its potential effects on reducing body fat, regenerating muscle cells, and supporting performance.
| Parameter | Value |
|---|---|
| Form | Capsules |
| Content | 50mg / capsule |
| Number of capsules | 30 capsules |
| Packaging | Glass jar with safety cap |
| Storage | Store in a dry place at room temperature |
| Molecular formula | C11H11N2O+ |
| Molecular weight | 187.22 g/mol |
| IUPAC name | 5-amino-1-methylquinolinium |
| Other names | NNMT inhibitor, 5-Amino-1MQ |
In laboratory studies, 5-Amino-1MQ has been investigated in the following areas:
- inhibition of the NNMT enzyme and increase in NAD⁺ levels,
- reduction of body fat while maintaining muscle mass,
- improvement of endurance and energy metabolism,
- research in the field of obesity and metabolic diseases,
- support of mitochondrial function and cell regeneration.
Possible Side Effects
No serious side effects were observed in preclinical tests. However, there are no clinical data in humans, so potential risks, interactions, and allergic reactions are unknown.
Resources
- Scientific Reports – NNMT Inhibition and Performance Improvement in Mice
- Peptides.org – 5-Amino-1MQ Profile and Research Insights
- PubChem, ChemSpider – Molecular and Chemical Data
| Weight | 0,2 kg |
|---|
